A new prognostic staging system for rectal cancer

Annals of Surgery

Volumn 240, Issue 5, 2004, Pages 832-839

  Ueno, Hideki ^a   Price, Ashley B ^b   Wilkinson, Kay H ^b   Jass, Jeremy R ^c   Mochizuki, Hidetaka ^a   Talbot, Ian C ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b ST MARK S HOSPITAL   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECTUM CARCINOMA; REPRODUCIBILITY; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 7044246090     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000143243.81014.f2     Document Type: Article

References (39)

1. Dukes C. The classification of cancer of the rectum. J Pathol Bacteriol. 1932;35:323-332.
2. Gabriel WB, Dukes C, Bussey HJ. Lymphatic spread in cancer of the rectum. Br J Surg. 1935;23:395-413.
3. Kirklin JW, Dockerty MB, Waugh JM. The role of the peritoneal reflection in the prognosis of carcinoma of the rectum and sigmoid colon. Surg Gynecol Obstet. 1949;88:326-331.
4. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer. 1974;34:1278-1292.
5. Whittaker M, Goligher JC. The prognosis after surgical treatment for carcinoma of the rectum. Br J Surg. 1976;63:384-388.
6. Pihl E, Hughes ES, McDermott FT, et al. Carcinoma of the rectum and rectosigmoid: cancer specific long-term survival: a series of 1061 cases treated by one surgeon. Cancer. 1980;45:2902-2907.
7. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of colon and rectum. Ann Surg. 1954;139:846-852.
8. Fleming ID, American Joint Committee on Cancer, American Cancer Society, American College of Surgeons. AJCC Cancer Staging Manual. 5th Edition. Philadelphia: Lippincott-Raven; 1997.
9. Jass JR, Love SB, Northover JMA. A new prognostic classification of rectal cancer. Lancet 1987;June 6:1303-1306.
10. Fitzgerald RH. What is the Dukes' system for carcinoma of the rectum? Dis Colon Rectum. 1982;25:474-477.
11. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum. 1993; 36:627-635.
12. Harrison JC, Dean PJ, El-Zeky F, et al. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994; 25:498-505.
13. Fielding LP, Phillips RKS, Fry JS, et al. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986; October 18:904-906.
14. Michelassi F, Ayala JJ, Balestracci T, et al. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann Surg. 1991;214:11-18.
15. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994;69:979-985.
16. Morodomi T, Isomoto H, Shirouzu K, et al. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer. 1989;63:539-543.
17. Goldstein NS, Hart J. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Anat Pathol. 1999;111:51-58.
18. Okuyama T, Oya M, Ishikawa H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum. 2002;45:628-634.
19. Ueno H, Mochizuki H, Shinto E, et al. Histological indices in biopsy specimens for estimating the probability of extended local spread in rectal cancer. Cancer. 2002;94:2882-2891.
20. Ueno H, Mochizuki H, Hatsuse K, et al. Indicators for treatment strategies of colorectal liver metastases. Ann Surg. 2000;231:59-66.
21. Ueno H, Murphy J, Jass JR, et al. Tumour "budding" as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127-132.
22. Morson BC, Dawson IMP, Day DW, et al. Morson & Dawson's Gastrointestinal Pathology-third edition. Oxford and London: Blackwell Scientific Publications; 1990.
23. Dukes C. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1959;12:309-320.
24. Gabbert H. Mechanism of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev. 1985;4:293-309.
25. Pyke C, Salo S, Ralfkiær E, et al. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 1995;55:4132-4139.
26. Sordat I, Rousselle P, Chaubert P, et al. Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment. Int J Cancer. 2000;88:708-717.
27. Masaki T, Goto A, Sugiyama M, et al. Possible contribution of CD44 variant 6 and nuclear β-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma. Cancer. 2001;92: 2539-2546.
28. Fujiya M, Watari J, Ashida T, et al. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res. 2001;92:1074-1081.
29. Bekku S, Mochizuki H, Yamamoto T, et al. Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepato-Gastroenterol. 2000;47:998-1001.
30. Talbot IC, Ritchie S, Leighton M, et al. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology. 1981;5:141-163.
31. Deans GT, Heatley M, Anderson N, et al. Jass' classification revisited. J Am Coll Surg. 1994;179:11-17.
32. Jass JR, Ajioka Y, Allen JP, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology. 1996; 28:543-548.
33. Shepherd NA, Saraga EP, Love SB, et al. Prognostic factors in colonic cancer. Histopathology. 1989;14:613-620.
34. Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986; November 1:996-998.
35. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344:707-711.
36. Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;i:1479-1482.
37. Rankin FW, Broders AC. Factors influencing prognosis in carcinoma of the rectum. Surg Gynecol Obstet. 1928;46:660-667.
38. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: histological perspectives and a multivariate analysis of 447 cases. Histopathology. 1986;10:437-459.
39. Hall PA, Going JJ. Predicting the future: a critical appraisal of cancer prognosis studies. Histopathology. 1999;35:489-494.